Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas

NCT03071822 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Peripheral T Cell Lymphoma

Interventions

DRUG: cisplatin
DRUG: ifosfamide
DRUG: gemcitabine
DRUG: L-asparaginase
DRUG: etoposide
DRUG: dexamethasone

Sponsor

The University of Hong Kong